CLINICAL STUDY: MYOCARDIAL INFARCTION
Decreasing hospital mortality between 1994 and 1998 in patients with acute myocardial infarction treated with primary angioplasty but not in patients treated with intravenous thrombolysis
Results from the pooled data of the maximal individual therapy in acute myocardial infarction (MITRA) registry and the myocardial infarction registry (MIR)
Ralf Zahn, MD*,
Rudolf Schiele, MD*,
Steffen Schneider, PhD*,
Anselm K. Gitt, MD*,
Harm Wienbergen, MD*,
Karlheinz Seidl, MD*,
Claus Bossaller, MD ,
Heinz J. Büttner, MD ,
Martin Gottwik, MD ,
Ernst Altmann, MD||,
Werner Rosahl, MD¶,
Jochen Senges, MD, FACC* for the Maximal Individual Therapy in Acute Myocardial Infarction (MITRA) and the Myocardial Infarction Registry (MIR) Study Groups
* Herzzentrum Ludwigshafen, Kardiologie, Ludwigshafen, Germany
the Robert Koch Krankenhaus, Gehrden, Germany
the Herzzentrum, Bad Krozingen, Germany
the Städtisches Klinikum, Nürnberg, Germany
|| the Klinikum Friedrichstadt, Dresden, Germany
¶ the Städtisches Klinikum, Dessau, Germany
Manuscript received March 3, 2000;
revised manuscript received May 22, 2000,
accepted July 13, 2000.
Reprint requests and correspondence: Dr. Ralf Zahn, Herzzentrum Ludwigshafen, Department of Cardiology, Bremserstraße 79, D - 67063 Ludwigshafen, Germany
erzahn{at}aol.com
OBJECTIVES
We investigated changes in the clinical outcome of primary angioplasty and thrombolysis for the treatment of acute myocardial infarction (AMI) from 1994 to 1998.
BACKGROUND
Primary angioplasty for the treatment of AMI is a sophisticated technical procedure that requires experienced personnel and optimized hospital logistics. Growing experience with primary angioplasty in clinical routine and new adjunctive therapies may have improved the outcome over the years.
METHODS
The pooled data of two German AMI registries: the Maximal Individual Therapy in AMI (MITRA) study and the Myocardial Infarction Registry (MIR) were analyzed.
RESULTS
Of 10,118 lytic eligible patients with AMI, 1,385 (13.7%) were treated with primary angioplasty, and 8,733 (86.3%) received intravenous thrombolysis. Patients characteristics were quite balanced between the two treatment groups, but there was a higher proportion of patients with a prehospital delay of >6 h in those treated with primary angioplasty. The proportion of an in-hospital delay of more than 90 min significantly decreased in patients treated with primary angioplasty over the years (p for trend = 0.015, multivariate odds ratio [OR] for each year of the observation period = 0.84, 95% confidence interval [CI]: 0.73– 0.96) but did not change significantly in patients treated with thrombolysis. Hospital mortality decreased significantly in the primary angioplasty group (p = 0.003 for trend; multivariate OR for each year = 0.73, 95% CI: 0.58– 0.93). However, for patients treated with thrombolysis, hospital mortality did not change significantly (p for trend 0.175, multivariate OR for each year: 1.02, 95% CI: 0.94– 1.11).
CONCLUSIONS
Compared with thrombolysis the clinical results of primary angioplasty for the treatment of AMI improved from 1994 to 1998. This indicates a beneficial effect of the growing experience and optimized hospital logistics of this technique over the years.
|
Abbreviations and Acronyms
| | ACE | = angiotensin-converting enzyme | | AMI | = acute myocardial infarction | | CI | = confidence interval | | MIR | = Myocardial Infarction Registry | | MITI | = Myocardial Infarction Triage Investigators Registry | | MITRA | = Maximal Individual Therapy in Acute Myocardial Infarction Registry | | NRMI-2 registry | = National Registry of Myocardial Infarction-2 | | OR | = odds ratio |
|
This article has been cited by other articles:
|
|
|
|
 
P. B. Berger and P. J.M. Best
Does Kidney Function Alter the Benefit of Reperfusion Therapy for ST-Segment Elevation Myocardial Infarction?
J. Am. Coll. Cardiol. Intv.,
January 1, 2009;
2(1):
34 - 36.
[Full Text]
[PDF]
|
|
|
|
|
|
|
G. W. Stone
Angioplasty Strategies in ST-Segment-Elevation Myocardial Infarction: Part I: Primary Percutaneous Coronary Intervention
Circulation,
July 29, 2008;
118(5):
538 - 551.
[Full Text]
[PDF]
|
|
|
|
|
|
|
G. W. Stone
Angioplasty Strategies in ST-Segment-Elevation Myocardial Infarction: Part II: Intervention After Fibrinolytic Therapy, Integrated Treatment Recommendations, and Future Directions
Circulation,
July 29, 2008;
118(5):
552 - 566.
[Full Text]
[PDF]
|
|
|
|
|
|
|
A-A Fassa, P Urban, D Radovanovic, N Duvoisin, J-M Gaspoz, J-C Stauffer, P Erne, and for the AMIS Plus Investigators
Trends in reperfusion therapy of ST segment elevation myocardial infarction in Switzerland: six year results from a nationwide registry
Heart,
July 1, 2005;
91(7):
882 - 888.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
Authors/Task Force Members, S. Silber, P. Albertsson, F. F. Aviles, P. G. Camici, A. Colombo, C. Hamm, E. Jorgensen, J. Marco, J.-E. Nordrehaug, et al.
Guidelines for Percutaneous Coronary Interventions: The Task Force for Percutaneous Coronary Interventions of the European Society of Cardiology
Eur. Heart J.,
April 2, 2005;
26(8):
804 - 847.
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. Di Donato, A. Frigiola, M. Benhamouda, and L. Menicanti
Safety and Efficacy of Surgical Ventricular Restoration in Unstable Patients With Recent Anterior Myocardial Infarction
Circulation,
September 14, 2004;
110(11_suppl_1):
II-169 - II-173.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. Singh, H. H. Ting, B. J. Gersh, P. B. Berger, R. J. Lennon, D. R. Holmes Jr, and K. N. Garratt
Percutaneous Coronary Intervention for ST-Segment and Non-ST-Segment Elevation Myocardial Infarction at Hospitals With and Without On-site Cardiac Surgical Capability
Mayo Clin. Proc.,
June 1, 2004;
79(6):
738 - 744.
[Abstract]
[PDF]
|
|
|
|
|
|
|
P. A. Lemos, F. Saia, S. H. Hofma, J. Daemen, A. T. L. Ong, C. A. Arampatzis, A. Hoye, E. McFadden, G. Sianos, P. C. Smits, et al.
Short- and long-term clinical benefit of sirolimus-eluting stents compared to conventional bare stents for patients with acute myocardial infarction
J. Am. Coll. Cardiol.,
February 18, 2004;
43(4):
704 - 708.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
P. Widimsky
Reperfusion damage or no-reflow damage in primary coronary interventions in acute myocardial infarction?
Eur. Heart J.,
July 2, 2002;
23(14):
1076 - 1078.
[Full Text]
[PDF]
|
|
|
|
|
|
|
J. M. Albes, M. Gross, U. Franke, J. Wippermann, T. U. Cohnert, R. Vollandt, and T. Wahlers
Revascularization during acute myocardial infarction: risks and benefits revisited
Ann. Thorac. Surg.,
July 1, 2002;
74(1):
102 - 108.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. Singh, H. H. Ting, P. B. Berger, K. N. Garratt, D. R. Holmes Jr, and B. J. Gersh
Rationale for on-site cardiac surgery for primary angioplasty: a time for reappraisal
J. Am. Coll. Cardiol.,
June 19, 2002;
39(12):
1881 - 1889.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
E.P. McFadden
Fibrinolysis and stenting in acute myocardial infarction: newlyweds destined for a 'menage a trois'?
Eur. Heart J.,
July 1, 2001;
22(13):
1067 - 1069.
[PDF]
|
|
|
|
|
|
|
N. R. Every and K. G. Lehmann
The effectiveness of primary PTCA: does patient risk matter?
J. Am. Coll. Cardiol.,
June 1, 2001;
37(7):
1836 - 1838.
[Full Text]
[PDF]
|
|
|
|
